Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole controlled release pharmacokinetics and food-effect in restless legs syndrome
2006-002139-26Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Primary endpoint: Ropinirole AUC(0-τ). Started Oct 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2006-002139-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002139-26.